Lacerta Bio is seeking parenteral products for in-licensing on behalf of a US-based client.
Key criteria are:
Products which can be developed via the 505(b)(2) regulatory process in the US
No specific therapeutic area
Injectable could be infusion, prefilled syringe, or related presentation
Products already approved outside the US are especially welcome
Delivery / formulation technologies may also be of interest
Companies with products or technologies which fit these criteria may contact us via the form below: